8-Epi-PGF(2α) induces airflow obstruction and airway plasma exudation in vivo

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 2, 1997, Pages 436-441

  Okazawa, Akira ^b   Kawikova, Ivana ^b   Cui, Zui Hua ^b   Skoogh, Bengt Eric ^b   Lötvall, Jan ^a  

^a Lung Pharmacology Group   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN; PROSTANOID; THROMBOXANE RECEPTOR; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; ANTIHISTAMINIC AGENT; ANTITHROMBOCYTIC AGENT; CARBAZOLE DERIVATIVE; DRUG DERIVATIVE; METHACRYLIC ACID DERIVATIVE; OZAGREL; PROSTAGLANDIN F2 ALPHA; RAMATROBAN; SULFONAMIDE; THROMBOXANE A2; THROMBOXANE B2; VASOCONSTRICTOR AGENT;

AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENZYME ACTIVITY; GUINEA PIG; LIPID PEROXIDATION; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG ANTAGONISM; MALE;

AIRWAY OBSTRUCTION; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CARBAZOLES; DINOPROST; GUINEA PIGS; HISTAMINE ANTAGONISTS; MALE; METHACRYLATES; PLATELET AGGREGATION INHIBITORS; SULFONAMIDES; THROMBOXANE A2; THROMBOXANE B2; VASOCONSTRICTOR AGENTS;

EID: 0030614482     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.2.9032175     Document Type: Article

References (31)

1. Morrow, J. D., T. M. Harris, and L. J. Roberts, II. 1990. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184:1-10.
2. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U.S.A. 87:9383-9387.
3. 2α is formed in vivo. Biochim. Biophys. Acta 1210:244-248.
4. 2 receptors. J. Clin. Invest. 90:136-141.
5. 2α, in rabbit lung in situ. Am. J. Physiol. 263:H660-H663.
6. 2α in isolated perfused rat lung. J. Appl. Physiol. 74:460-465.
7. 2α, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Am. J. Respir. Crit. Care Med. 153:590-596.
8. 2α in the airways of human subjects. Am. J. Respir. Cell Mol. Biol. 9:568-572.
9. 2-isoprostanes) in smokers, as a cause of oxidative damage. N. Engl. J. Med. 332: 1198-1203.
10. 2α, in pulmonary oxygen toxicity. J. Appl. Physiol. 77:2912-2917.
11. von Neergaard, K., and K. Wirz. 1927. Die messung der strömungswiderstände in den atemwegem des menschen, insbestondere bei asthma und emphysem. Z. Klin. Med. 105:51-82.
12. Fiedler, V. B., E. Perzborn, F. Seuter, U. Rosentreter, and H. Böshagen. 1989. Reduction of in vivo coronary artery thrombosis by the novel thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropanoic acid. Arzneim.-Forsch./Drug Res. 39:1527-1530.
13. Piper, P. J., H. O. J. Collier, and J. R. Vane. 1967. Release of catecholamines in the guinea-pig by substances involved in anaphylaxis. Nature 213:838-890.
14. Lötvall, J., W. Elwood, K. Tokuyama, T. Sakamoto, P. J. Barnes, and K. F. Chung. 1992. A thromboxane mimetic, U-46619, produces plasma exudation in airways of the guinea pig. J. Appl. Physiol. 72:2415-2419.
15. 2α-induced airflow obstruction and airway plasma exudation in guinea-pig: role of thromboxane and its receptor. Br. J. Pharmacol. 110:127-132.
16. 2 mimetic) induces airflow obstruction and airway plasma extravasation in guinea pig: the role of histamine, cyclooxygenase metabolites, leukolriene and PAF. J. Pharmacol. Exp. Ther. 278:268-276.
17. Lötvall, J. O., R. J. Lernen, K. P. Hui, P. J. Barnes, and K. F. Chung. 1990. Airflow obstruction after substance P aerosol: contribution of airway and pulmonary edema. J. Appl. Physiol. 69:1473-1478.
18. 2 receptor antagonist on airway smooth muscle in vitro. Br. J. Pharmacol. 104: 585-590.
19. 2-induced bronchoconstriction in the guinea-pig. Br. J. Pharmacol. 104:596-602.
20. 2-isoprostane receptors on rat vascular smooth muscle cells. Am. J. Physiol. 264: C1619-C1624.
21. 2 into bronchoalveolar lavage fluid of guinea pigs: relationship to airflow obstruction. Eur. J. Phamacol. 280:293-299.
22. Nambu, F., M. Motoishi, N. Omawari, T. Okegawa, A. Kawasaki, and S. Ikeda. 1990. Inhibitory effects of OKY-046 on spasmogen-induced bronchoconstrictions in sensitized and non-sensitized guinea pigs. Jpn. J. Pharmacol. 52:307-317.
23. Arakawa, H., I. Kawikova, C. G. Lofdahl, and J. Lötvall. 1992. Bradykinin-induced airway responses in guinea pig: effects of inhibition of cyclooxygenase and thromboxane synthetase. Eur. J. Phamacol. 229:131-136.
24. 2 or leukotrienes. Br. J. Pharmacol. 110:657-664.
25. 2 in airway microvascular leakage induced by inhaled platelet-activating factor. J. Appl. Physiol. 71:1729-1734.
26. 2α. J. Biol. Chem. 270:9800-9808.
27. 2α excretion in man. J. Pharmacol. Exp. Ther. 275:94-100.
28. Barnes, P. J. 1990. Reactive oxygen species and airway inflammation. Free Radic. Biol. Med. 9:235-243.
29. 2- and exercise-induced bronchoconstriction. J. Allergy Clin. Immunol. 89:1119-1126.
30. 2- and allergen-induced bronchoconstriction. J. Appl. Physiol. 66:1685-1693.
31. Stenton, S. C., C. A. Young, A. Harris, J. B. D. Palmer, D. J. Hendrick, and E. H. Walters. 1992. The effect of GR32191 (a thromboxane receptor antagonist) on airway responsiveness in asthma. Pulm. Pharmacol. 5:199-202.